收藏切换
Evaluation of the rationality of pentoxifylline injection in patients with cerebral infarction caused by cerebral artery stenosis based on the attribute hierarchy model
收藏切换
Chunmei WANG, Yangyang WANG, Panpan DI*
World Clinical Drug | 2025, 46(7) : 708 - 714
Less
收藏切换
World Clinical Drug | 2025, 46(7): 708-714
• Article •
Evaluation of the rationality of pentoxifylline injection in patients with cerebral infarction caused by cerebral artery stenosis based on the attribute hierarchy model
Full
Chunmei WANG, Yangyang WANG, Panpan DI*
Affiliations
  • Department of Pharmacy, the Affiliated Bozhou Hospital of Anhui Medical University, Bozhou 236800, Anhui Province, China
Published: 2025-07-10 doi: 10.13683/j.wph.2025.07.014
Outline
收藏切换
Objective

To establish the evaluation criteria for the rational use of pentoxifylline injection in patients with cerebral infarction(CI) caused by cerebral artery stenosis, and to provide a basis for rational clinical drug use.

Methods

Based on the instructions of pentoxifylline injection, relevant guidelines for CI caused by cerebral artery stenosis, and previous literature, the evaluation criteria were formulated. The attribute hierarchy model(AHM) was used to evaluate 292 cases of cerebral artery stenosis CI discharged patients who treated with pentoxifylline injection in our hospital from March 2023 to August 2024.

Result

In the evaluation of the rationality of the results, The relative weights of the indicators,from largest to smallest, are indications(0.1545), dosage and administration(0.1360), contraindications(0.1199),adverse reactions(0.1087), solvent selection(0.1008), drug interactions(0.1002), course of treatment(0.0955),precautions(0.0932), and route of administration(0.0912). Five patients(1.71%) had cases of exceeding contraindications and not following the precautions. Among them, the total deduction score of the visiting department was 106.55 points, with the deduction score for contraindications accounting for 56.26% and the deduction score for precautions accounting for 43.74%. There were 287 cases(98.29%) with excellent case scores and 5 cases(1.71%) with qualified cases.Contraindications and precautions showed significant differences in the score comparison(P<0.001).

Conclusion

The use of AHM to evaluate the rationality of pentoxifylline injection in CI patients caused by cerebral artery stenosis has clinical value. The current medication regimens are generally in line with the norms, but improvements are still needed in the screening of contraindications and medication monitoring. It is suggested to optimize management through measures such as strengthening multi-disciplinary collaboration, improving the electronic system for medication contraindications, and enhancing the review of pharmacists' prescriptions and medication education.

cerebral infarction caused by cerebral artery stenosis  /  pentoxifylline injection  /  attribute hierarchy model  /  application rationality
王春梅, 汪洋洋, 狄潘潘. 基于属性层次模型的大脑动脉狭窄脑梗死患者己酮可可碱应用合理性评价. 世界临床药物, 2025 , 46 (7) : 708 -714 . DOI: 10.13683/j.wph.2025.07.014
Chunmei WANG, Yangyang WANG, Panpan DI. Evaluation of the rationality of pentoxifylline injection in patients with cerebral infarction caused by cerebral artery stenosis based on the attribute hierarchy model[J]. World Clinical Drug, 2025 , 46 (7) : 708 -714 . DOI: 10.13683/j.wph.2025.07.014
Year 2025 volume 46 Issue 7
45
10
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.07.014
  • Receive Date:2025-02-02
  • Online Date:2026-11-09
  • Published:2025-07-10
Article Data
Affiliations
History
  • Received:2025-02-02
Affiliations
    Department of Pharmacy, the Affiliated Bozhou Hospital of Anhui Medical University, Bozhou 236800, Anhui Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.07.014
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT